Skip to main menu Skip to main content Skip to footer

Retina World Congress 2026

May 14 – 17, 2026 Fort Lauderdale, Florida

A Root Cause Analysis of Surgery-Related Adverse Events With Revakinagene Taroretcel-lwey in Macular Telangiectasia Type 2 Clinical Trials

Ellipsoid Zone Area Loss: An Independent Predictor of Reduced Fixation Stability in Patients With Macular Telangiectasia Type 2

Reading Speed Outcomes in Macular Telangiectasia Type 2: Sham-Control Data From the Revakinagene Taroretcel-lwey Phase 3 Clinical Trials